CERo Therapeutics Warrants
CEROW
CEROW was delisted on the 30th of October, 2025.
49 hedge funds and large institutions have $3.54M invested in CERo Therapeutics Warrants in 2022 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 8 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
75% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 8
14% more funds holding
Funds holding: 43 → 49 (+6)
5% less capital invested
Capital invested by funds: $3.72M → $3.54M (-$181K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$19.7K |
| 2 |
CCA
Castle Creek Arbitrage
Avon,
Colorado
|
+$10.5K |
| 3 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
+$3.94K |
| 4 |
DCM
Difesa Capital Management
New York
|
+$3.29K |
| 5 |
CAC
Cowen and Company
New York
|
+$3.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$17K |
| 2 |
AGM
Alpine Global Management
New York
|
-$8K |
| 3 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$6K |
| 4 |
HIM
HGC Investment Management
Toronto,
Ontario, Canada
|
-$4K |
| 5 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KPF
51
K2 Principal Fund
Toronto,
Ontario, Canada
| – | -$6K | -75,000 | Closed |
|
|
AGM
52
Alpine Global Management
New York
| – | -$8K | -55,600 | Closed |
|
|
HIM
53
HGC Investment Management
Toronto,
Ontario, Canada
| – | -$4K | -50,000 | Closed |
|
|
BCM
54
Basso Capital Management
Stamford,
Connecticut
| – | -$3K | -37,480 | Closed |
|
55
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$2K | -27,699 | Closed |
|
|
WP
56
Woodline Partners
San Francisco,
California
| – | -$1K | -12,500 | Closed |
|
|
RA
57
Ramius Advisors
New York
| – | -$1K | -10,500 | Closed |
|
CEROW Hedge Fund Activity: Q4 2022 in Review
49 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics Warrants (CEROW) for Q4 2022, worth a combined $3.54M — down 4.9% from $3.72M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new CEROW positions and 8 closed out — a net gain of 6 holders — while 4 added to existing stakes and 2 trimmed.
The largest buyer was Shaolin Capital Management, opening a new position worth an estimated $19.7K. The largest seller was Magnetar Financial, exiting entirely with an estimated $17K sold.
- 49 institutional investors held CERo Therapeutics Warrants (CEROW) as of Q4 2022, up from 43 in Q3 2022.
- Funds reported $3.54M of CERo Therapeutics Warrants stock for Q4 2022, down 4.9% quarter-over-quarter.
- 14 funds opened new CERo Therapeutics Warrants positions in Q4 2022 and 8 closed out, a net change of +6 holders.
- The largest CERo Therapeutics Warrants buyer in Q4 2022 was Shaolin Capital Management, an estimated $19.7K added.
- The largest CERo Therapeutics Warrants seller in Q4 2022 was Magnetar Financial, an estimated $17K sold.
Based on aggregated 13F filings for Q4 2022.